Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,031,880
-$4,301 QoQ
Shares Held
4,063
-4.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#2,987
of 4,664 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Walkner Condon Financial Advisors LLC holds $5,850,924 across 8 Drug Manufacturers - General names. JNJ ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,536 | $1,842,324 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
4,063 | $1,031,880 | |
| 3 | ABBV |
AbbVie Inc.
|
2,816 | $708,618 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
5,409 | $683,373 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,354 | $559,489 | |
| 6 | NVS |
Novartis AG
|
2,701 | $423,300 | |
| 7 | AMGN |
Amgen Inc
|
1,035 | $374,794 | |
| 8 | PFE |
Pfizer Inc
|
9,433 | $227,146 |
All Filings in JNJ
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,031,880 | 4,063 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,036,181 | 4,239 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $889,885 | 4,300 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $708,118 | 3,819 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $502,700 | 3,291 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $526,873 | 3,177 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $367,334 | 2,540 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $460,736 | 2,843 | Shares | Sole | 2024-10-31 | |
| 2024-03-31 | $450,683 | 2,849 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $407,680 | 2,601 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $305,581 | 1,962 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $321,108 | 1,940 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $313,255 | 2,021 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $394,282 | 2,232 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $374,421 | 2,292 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $409,515 | 2,307 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $286,049 | 1,614 | Shares | Sole | 2022-05-03 | |
| 2021-09-30 | $254,039 | 1,573 | Shares | Sole | 2021-11-04 | |
| No filing history on record for this holder in this stock. | ||||||